NCT02051049View on ClinicalTrials.gov

Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

February 28, 2019

Conditions
Urea Cycle DisordersCrigler Najjar Syndrome
Trial Locations (1)

1435

Promethera Biosciences, Mont-Saint-Guibert

Sponsors

Lead Sponsor

Cellaion SA
All Listed Sponsors
lead

Cellaion SA

INDUSTRY